Impact of Polypharmacy and P-Glycoprotein- And CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients With Atrial Fibrillation
Cardiovascular Drugs and Therapy- Netherlands
doi 10.1007/s10557-019-06907-8
Full Text
Abstract
Available in
Date
September 13, 2019
Authors
Publisher
Springer Science and Business Media LLC